Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SeaView Research was a prominent clinical research organization (CRO) specializing in early-phase drug development and clinical pharmacology. Founded in 1995 and headquartered in Miami, Florida, the company operated high-capacity clinical pharmacology units in Miami and Jacksonville with a combined capacity of 320 beds. SeaView was recognized for its expertise in complex clinical studies, including first-in-human investigations, drug-drug interactions, and biosimilar research. In February 2017, the company was acquired by Quotient Clinical (now Quotient Sciences) to expand its early-phase clinical footprint into the United States and integrate with the Translational Pharmaceutics platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seaview Fisheries.